1. Suppression of epithelial-mesenchymal transition and SIRT1/AKT signaling pathway in breast cancer by montelukast
   Nahla E. El-Ashmawy et al, 2023, International Immunopharmacology CrossRef
2. Effects of Montelukast on Arsenic-Induced Epithelial-Mesenchymal Transition and the Role of Reactive Oxygen Species Production in Human Bronchial Epithelial Cells
   Huang-Chi Chen et al, 2022, Frontiers in Pharmacology CrossRef
3. Montelukast Sodium to Prevent and Treat Bronchopulmonary Dysplasia in Very Preterm Infants: A Quasi-Randomized Controlled Trial
   Zhongyi Sun et al, 2023, Journal of Clinical Medicine CrossRef
4. The role of necroptosis in common respiratory diseases in children
   Junjie Ning et al, 2022, Frontiers in Pediatrics CrossRef
5. Montelukast induces beneficial behavioral outcomes and reduces inflammation in male and female rats
   Ira S. Rostevanov et al, 2022, Frontiers in Immunology CrossRef
6. Development of a blood proteins-based model for bronchopulmonary dysplasia prediction in premature infants
   Wanting Ou et al, 2023, BMC Pediatrics CrossRef
7. PGC-1α activity and mitochondrial dysfunction in preterm infants
   Atefeh Mohammadi et al, 2022, Frontiers in Physiology CrossRef
8. c-Myc Drives inflammation of the maternal-fetal interface, and neonatal lung remodeling induced by intra-amniotic inflammation
   April W. Tan et al, 2024, Frontiers in Cell and Developmental Biology CrossRef
9. CircRNA, lncRNA, and mRNA profiles of umbilical cord blood exosomes from preterm newborns showing bronchopulmonary dysplasia
   Yu Wang et al, 2022, European Journal of Pediatrics CrossRef
10. The role of rhIGF-1/BP3 in the prevention of pulmonary hypertension in bronchopulmonary dysplasia and its underlying mechanism
    Sehua Qu et al, 2023, BMC Pulmonary Medicine CrossRef